Resultados de la búsqueda 391-400 of 11474 for Low testosterone
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered To Renal Pelvis. Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The ...
Phase 1 Trial Of ST-001 NanoFenretinide In Relapsed/Refractory T-cell Non-Hodgkin Lymphoma · Actinium Therapy For Late-stage Aggressive Sarcomas · Low Dose ...
Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from ...
... T-cell (CAR-T) therapy. The most common adverse event after CAR-T therapy is lower than normal blood cells (cytopenia) and up to one third of patients ...
The purpose of this study is to evaluate a low-cost Contrast Enhanced ... This is a peripheral blood Collection Protocol to study the T-cell immune ...
The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.
However, the use of anti-inflammatory agents in the prevention of colorectal cancer is controversial, although there is some suggestion that its use may lower ...
No hay ningún médico cuyo apellido comience con dicha letra T T; No hay ... Low, Phillip A. M.D.. Minnesota. John Lucas. Lucas, John A. Ph.D. Florida. Lujan ...
No hay ningún médico cuyo apellido comience con dicha letra T T; No hay ... Low, Phillip A. M.D.. Minnesota. Lujan, Luis Ph.D., M.S.. Minnesota. Escrito por ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?